Possible relationship between Al/ferritin complex and Alzheimer's disease

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 89-93

  De Sole, Pasquale ^a   Rossi, Cristina ^a   Chiarpotto, Michela ^a   Ciasca, Gabriele ^b   Bocca, Beatrice ^c   Alimonti, Alessandro ^c   Bizzarro, Alessandra ^a   Rossi, Concetta ^a   Masullo, Carlo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CNR   (Italy)

^c National Health Institute   (Italy)

Author keywords

Aluminum; Alzheimer's disease; Ferritin; Iron

Indexed keywords

ALUMINUM; FERRITIN; IRON; ZINC;

ALZHEIMER DISEASE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEPTIC SHOCK;

ALUMINUM; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FERRITINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MASS SPECTROMETRY; SHOCK, SEPTIC; ZINC;

EID: 84871803726     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.10.023     Document Type: Article

References (31)

1. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275:161-203.
2. Ciasca G., Papi M., Chiarpotto M., Rodio M., Campi G., Rossi C., et al. Transient state kinetic investigation of ferritin iron release. Appl Phys Lett 2012, 100:73703-73705.
3. Minotti G., Aust S.D. The role of iron in oxygen radical mediated lipid peroxidation. Chem Biol Interact 1989, 71:1-19.
4. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984, 219:1-14.
5. De Valk B., Marx J.M. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999, 159:1542-1548.
6. Johnson S. Iron catalyzed oxidative damage, in spite of normal ferritin and transferrin saturation levels and its possible role in Werner's syndrome, Parkinson's disease, cancer, gout, rheumatoid arthritis, etc. Med Hypotheses 2000, 55:242-244.
7. Balla G., Jacob H.S., Balla J., et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992, 267:18148-18153.
8. Herbert V., Shaw S., Jayatilleke E., Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994, 12:289-303.
9. Arosio P., Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002, 33:457-463.
10. Cairo G., Recalcati S., Pietrangelo A., Minotti G. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 2002, 32:1237-1243.
11. Joshi J.G., Sczekan S.R., Fleming J.T. Ferritin a general metal detoxicant. Biol Trace Elem Res 1989, 21:105-110.
12. Grady J.K., Shao J., Arosio P., Santambrogio P., Chasteen N.D. Vanadyl (IV) binding to mammalian ferritins. An EPR study aided by site-directed mutagenesis. J Inorg Biochem 2000, 80:107-113.
13. Fleming J.T., Joshi J.G. Ferritin: the role of aluminium in ferritin function. Neurobiol Aging 1991, 12:413-418.
14. Sakamoto T., Ogasawara Y., Ishii K., Takahashi H., Tanabe S. Accumulation of aluminum in ferritin isolated from rat brain. Neurosci Lett 2004, 366:264-267.
15. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000, 71:621S-629S. (Suppl.).
16. Spada P.L., Rossi C., Alimonti A., Bocca B., Ricerca B.M., Bocci M.G., et al. Iron, zinc and aluminium ferritin content of hemodialysis hyperferritinemic patients: comparison with other hyperferritinemic clinical conditions and normoferritinemic blood donors. Clin Biochem 2009, 42:1654-1657.
17. Bharathi, Vasudevaraju P., Govindaraju M., Palanisamy A.P., Sambamurti K., Rao K.S.J. Molecular toxicity of aluminium in relation to neurodegeneration. Indian J Med Res 2008, 128:545-556.
18. Exley C. A molecular mechanism of aluminium-induced Alzheimer's disease?. J Inorg Biochem 1999, 76:133-140.
19. Bala M.V., Gupta V., Anitha S., Hegde M.L., Zecca L., Garruto R.M., Ravid R., et al. Aluminium in Alzheimer's disease: are we still at a crossroad?. Cell Mol Life Sci 2005, 62:143-158.
20. Bondy S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31:575-581.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
22. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
23. Katz S., Amasa B., Ford Roland W., Moskowitz B., Jackson A., Marjorie Jaffe W. Studies of illness in the aged. The index of ADL. A standardized measure of biological and psychosocial function. JAMA 1963, 185:914-920.
24. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
25. Yamanishi H., Iyama S., Yamaguchi Y., Kanakura Y., Iwatani Y. Relation between iron content of serum ferritin and clinical status factors extracted by factor analysis in patients with hyperferritinemia. Clin Biochem 2002, 35:523-529.
26. Spada P.L., Rossi C., Alimonti A., Bocca B., Cozza V., Ricerca B., et al. Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients. Clin Biochem 2008, 41:997-1001.
27. Tomljenovic L. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?. J Alzheimers Dis 2011, 23:567-598.
28. Ciasca G., Chiarpotto M., Campi G., Bocca B., Rodio M., Pino A., et al. Reconstitution of aluminium and iron core in horse spleen apoferritin. J Nanopart Res 2011, 13:6149-6155.
29. Joshi J.G., Clauberg M. Ferritin: an iron storage protein with diverse functions. Biofactors 1988, 1:207-212.
30. Lawson D.M., Artymiuk P.J., Yewdall S.J., Smith J.M.A., Livingstone J.C., Treffry A., et al. Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 1991, 349:541-544.
31. Perez M., Valpuesta J.M., Montejo de Garcini E., Quintana C., Arrasate M., Lòpez-Carrascosa J.L., et al. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 1998, 152:1531-1539.